Work

Multicenter phase I trial of sorafenib (S) in high-risk hepatocellular carcinoma (HCC) patients after liver transplantation (LT).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.285

Authors: Abby B. Siegel, Anthony B. El-Khoueiry, Richard S. Finn, Abhishek Goyal, Charles David Blanke, Robert S. Brown

Institutions: Columbia University, USC Norris Comprehensive Cancer Center, University of California, Los Angeles, Oregon Health & Science University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591220385

Cites:

Cited by:

Related to: 10